By Robert PreidtHealthDay Reporter TUESDAY, Dec. 8, 2020 (HealthDay News) — AstraZeneca’s COVID-19 vaccine is safe and effective, new data from late-stage trials shows. Overall, the vaccine protected against symptomatic disease in 70% of cases, according to a team led by researchers from Oxford University in England. Among study volunteers who got a … Read more
The complainant also demanded that the ongoing trials in India of the vaccine candidate be immediately halted. Vaccine major Serum Institute of India (SII) on Sunday strongly refuted an allegation that Covishield, the vaccine candidate for Covid-19, which is in the third phase of human trials in India, triggered adverse reaction in a Chennai-based 40-year-old … Read more
Oct. 16, 2020 — Pfizer won’t apply for emergency authorization of its coronavirus vaccine before the third week in November, the company’s chief executive said in a statement posted to Pfizer’s website on Friday. The reversal from the company’s previous claims that it would apply for the approval in October is a blow to … Read more